Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Devicor buys Neoprobe’s gamma detection product line

Executive Summary

Neoprobe Corp. (cancer devices and radiopharmaceuticals) has agreed to sell its neoprobe GDS gamma detection systems business to Devicor Medical Products Inc. (minimally invasive breast cancer diagnostic devices) for $30mm in cash up front. The deal also includes up to $20mm in royalties payable to Neoprobe if revenues from the acquired products exceed $21mm during any of the next five fiscal years.
Deal Industry
  • Medical Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Acquisition
    • Includes Contract
    • Payment Includes Cash
    • Full Acquisition
    • Includes Earnout

Related Companies